A hospital can fill beds, a skilled nursing facility can maintain census, and a physician group can increase visits while the broader system still produces avoidable cost and uneven outcomes. That is the central tension in fee for service vs value based care. The debate is no longer academic. It is a practical question of who gets paid, who carries financial risk, and whether operators can survive the transition without compromising access or quality.
For senior living, post-acute, home health, hospice, and hospital leaders, the answer cannot be reduced to a slogan about “better care.” Payment design shapes referral behavior, staffing models, documentation intensity, network strategy, capital allocation, and the willingness to take clinically complex patients. The more federal and commercial payers push accountability downstream, the more those decisions become enterprise-level strategy.
Value Based Care
Residing within CMS at the Centers for Medicare and Medicaid Innovation, the concept is one of many focused on creating efficiencies in primarily, government reimbursed healthcare – improving quality and reducing cost.
Established by the Affordable Care Act, CMMI operates within the Centers for Medicare and Medicaid Services (CMS) to test payment and service delivery models intended to lower costs while maintaining or improving quality—and to scale successful models as part of a new health care infrastructure. This authority has been central to advancing alternative payment models and moving Medicare and Medicaid away from pure fee-for-service toward value-based payment, reinforced by other ACA provisions and later laws such as the Medicare Access and CHIP Reauthorization Act of 2015.
After 16 years of work across all 50 states and billions of dollars in grants, the Center for Medicare and Medicaid Innovation’s push to shift U.S. health care from fee-for-service to value-based payment has largely stalled. CMS measurement rules, short pilot timeframes, and bureaucratic impatience have made it difficult to recognize and scale successful value-based payment models. Much of the problem is structural: the government’s scoring system is designed in a way that can make a pilot’s success nearly impossible to prove.
Fee for Service vs Value Based Care: The Core Difference
Fee-for-service payment is straightforward: providers are reimbursed for discrete, billable services. An office visit, procedure, therapy session, diagnostic test, hospital day, or home health episode generates payment according to an established rate and set of billing rules. The system rewards volume, coding accuracy, and the ability to provide reimbursable services efficiently.
Value-based care changes the unit of accountability. Rather than paying solely for each service delivered, the payer ties some portion of reimbursement to quality outcomes, total cost of care, patient experience, utilization patterns, or performance against a budget. Depending on the arrangement, the provider may receive a bonus for meeting targets, share in savings, accept downside risk for overruns, or receive a prospective payment intended to cover a defined population or episode.
That distinction matters because each model answers a different question. Fee-for-service asks whether a service was delivered and documented. Value-based care asks whether the organization helped achieve an acceptable outcome at an acceptable total cost.
Neither model is inherently pure in the real market. Most healthcare organizations operate in a blended environment. Medicare Advantage plans use various value-based arrangements with providers while still relying on fee schedules and encounter data. Accountable care organizations may have shared-savings incentives while their participating clinicians continue to bill fee-for-service. Post-acute providers can face bundled-payment pressures even when their base reimbursement remains largely prospective or episodic.
Why Fee-for-Service Has Been So Durable
Fee-for-service has obvious weaknesses, but its durability is not accidental. It is administratively familiar, relatively transparent at the service level, and compatible with a fragmented delivery system. A provider knows what services it offers, what documentation supports payment, and where revenue is generated.
For organizations operating on narrow margins, that predictability has value. Skilled nursing facilities, home health agencies, and hospitals cannot redesign their care models based solely on theoretical future savings. They have payroll, debt service, occupancy constraints, referral dependencies, and compliance obligations in the present.
Fee-for-service also supports access to specialized services that may be difficult to finance under a fixed budget. A patient with complex wounds, multiple chronic conditions, behavioral health needs, or advanced dementia can require substantial clinical resources. If risk adjustment is weak or payments do not accurately reflect acuity, value-based arrangements can create pressure to avoid the very patients who need coordinated care most.
The problem is that fee-for-service does little to reward coordination across settings. A hospital can be paid for an admission, a physician for visits, a skilled nursing facility for post-acute days, and a home health agency for services after discharge. Yet no one may be financially responsible for whether the patient understood the medication plan, had a timely primary care follow-up, or returned to the emergency department two weeks later.
The Promise and the Risk of Value-Based Care
Value-based care is built on a reasonable premise: payment should reward outcomes, not simply activity. If an organization can prevent avoidable hospitalizations, manage chronic disease earlier, coordinate transitions, and reduce duplicative care, it should share in the resulting savings.
For older adults with multiple conditions, the model can be particularly compelling. Medicare beneficiaries frequently move across hospitals, rehabilitation settings, physician offices, pharmacies, home health agencies, and long-term care providers. Fragmentation is not a minor inconvenience in this population. It drives medication errors, caregiver strain, preventable readmissions, and unnecessary spending.
But value-based care does not eliminate financial incentives. It relocates them. Under fee-for-service, the incentive is to provide more reimbursable care. Under capitation or meaningful downside risk, the incentive can become avoiding utilization, narrowing networks, or limiting access to expensive services. Policymakers and operators should be candid about that trade-off.
The integrity of a value-based model depends on several operational realities: accurate risk adjustment, credible quality measures, timely data, protections against patient selection, and enough financial capacity for providers to manage volatility. Without those conditions, a value-based contract can become a reimbursement cut disguised as reform.
That concern is especially relevant for smaller post-acute and senior care operators. Large health systems, national Medicare Advantage plans, and well-capitalized provider platforms can invest in analytics, care management teams, coding infrastructure, and actuarial expertise. Independent operators may be asked to accept performance risk without access to the data or negotiating leverage needed to manage it. That is not a level playing field.
What the Shift Means for Senior Care Operators
The strategic question is not whether value-based care will continue to expand. It will. The more useful question is where an organization should participate, what risk it can reasonably assume, and what capabilities it must develop before signing a contract.
Senior care providers should start with their actual role in the care continuum. A skilled nursing provider with strong hospital relationships and a demonstrably low readmission rate may be positioned to participate in preferred networks or episode-based arrangements. A home health agency with strong clinical outcomes may be able to support Medicare Advantage plans seeking to manage high-cost members at home. A life plan community may have an opportunity to differentiate around coordinated aging services, although its payment mechanics may differ from Medicare provider models.
The critical work is operational, not rhetorical. Leaders need reliable data on rehospitalizations, emergency department use, length of stay, medication reconciliation, therapy utilization, staffing stability, patient mix, and referral source performance. They also need to understand which outcomes they can control and which are driven by upstream discharge practices, local physician access, family support, or social determinants of health.
Contracting discipline is equally important. An attractive shared-savings proposal can be economically meaningless if the benchmark is unrealistic, attribution is unstable, quality thresholds are difficult to meet, or the payer retains broad discretion over data and methodology. Downside risk should never be accepted merely because a payer labels the arrangement “value-based.”
Operators should ask direct questions: What population is included? How is acuity measured? What services are excluded from the cost target? How often will performance data be delivered? Who controls utilization management? What happens when a patient requires high-cost care that is clinically appropriate? The answers reveal whether the arrangement is a genuine partnership or simply risk transfer.
Federal Policy Will Keep Moving the Market
CMS has steadily used demonstrations, accountable care models, bundled-payment concepts, quality programs, and Medicare Advantage policy to move providers toward greater accountability. The pace may change with administrations and congressional priorities, but the direction is durable because federal healthcare spending remains under pressure.
Medicare cannot sustain indefinite growth in utilization without confronting value, pricing, and care coordination. That fiscal reality will continue to shape payment policy. However, policymakers should resist the temptation to treat provider risk as a substitute for reform. Shifting financial exposure from government to providers does not automatically lower cost or improve care. It can simply concentrate market power in large organizations that have the capital to absorb losses.
The policy objective should be accountable care with safeguards, not indiscriminate risk transfer. That means better measures, transparent methodologies, meaningful patient protections, and payment levels that recognize the complexity of caring for medically fragile older adults.
The Strategic Position to Take Now
Fee-for-service will not disappear, and value-based care will not become a universal cure for healthcare’s cost and quality failures. The market will remain hybrid for years. Leaders who treat the transition as an all-or-nothing choice will make poor capital and contracting decisions.
The stronger position is to preserve excellence in core operations while building the clinical, data, and contracting capabilities needed to succeed under accountability. Improve transitions. Measure avoidable utilization. Know the true cost of serving high-acuity residents and patients. Refuse risk arrangements that cannot be priced or managed.
For senior care leaders, the most valuable asset in this transition is not a fashionable payment label. It is the ability to demonstrate, with credible data and disciplined operations, that your organization can care for complex people well when the system finally begins paying for what matters.
In a follow-up post, I will provide additional insight on where CMS plans to head in terms of accountable care, physician payment, and the movement toward more integrated medicine and preventative care. For now, the CMS teaser is available here: CMS Proposes Transformational Medicare Reforms to Expand Accountable Care, Modernize Physician Payment, and Shift from Sick Care to Healthcare | CMS
